These innovative medications , Retatrutide, represent a groundbreaking advancement in addressing obesity and conceivably other conditions . They are classified as GLP-1 pathway stimulators, indicating they function to replicate the endogenous GLP-1 hormone , boosting metabolic production and suppressing hunger . Despite Retatrutide each operates la